Literature DB >> 28867381

Using the National Cancer Database to create a scoring system that identifies patients with early-stage esophageal cancer at risk for nodal metastases.

Benny Weksler1, Kevin F Kennedy2, Jennifer L Sullivan3.   

Abstract

OBJECTIVES: Endoscopic resection is gaining popularity as a treatment for early-stage esophageal adenocarcinoma, particularly for T1a tumors. The goal of this study was to create a scoring system to reflect the risk of nodal metastases in early-stage esophageal adenocarcinoma to be used after endoscopic resection to better individualize treatment.
METHODS: The National Cancer Database was queried for patients with T1a or T1b esophageal adenocarcinoma who underwent esophagectomy. We identified variables affecting nodal metastases using multivariable logistic regression, which we then used to create a scoring system. We stratified the model for T1a or T1b tumors, tested model discrimination, and validated the models by refitting in 1000 bootstrap samples. C-statistics greater than 0.7 were considered relevant.
RESULTS: We identified 1283 patients with T1a or T1b tumors; 146 had nodal metastases (11.4%). Tumor category (pT1a vs pT1b), grade, and size and the presence of angiolymphatic invasion significantly affected the risk of nodal metastases. We assigned points to each variable and added them to get a risk score. In patients with T1a tumors, less than 3% of patients with a risk score of 3 or less had nodal metastases, whereas 16.1% of patients with a risk score of 5 or greater had nodal metastases. In patients with T1b tumors, less than 5% of patients with a risk score of 2 or less had nodal metastases, whereas 41% of patients with a score of 6 or greater had nodal metastases (c-statistic = 0.805).
CONCLUSIONS: The proposed scoring system seems to be useful in discriminating risk of nodal metastases in patients with T1a or T1b esophageal adenocarcinoma and may be useful in directing patients who received endoscopic resection to esophagectomy or careful follow-up.
Copyright © 2017 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  early stage; endoscopic therapy; esophageal cancer; esophagectomy; nodal metastases

Mesh:

Year:  2017        PMID: 28867381     DOI: 10.1016/j.jtcvs.2017.07.036

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  17 in total

1.  Ongoing Challenges with Clinical Assessment of Nodal Status in T1 Esophageal Adenocarcinoma.

Authors:  Tamar B Nobel; Arianna Barbetta; Meier Hsu; Kay See Tan; Smita Sihag; Manjit S Bains; David R Jones; Daniela Molena
Journal:  J Am Coll Surg       Date:  2019-05-17       Impact factor: 6.113

2.  Infiltration Depth is the Most Relevant Risk Factor for Overall Metastases in Early Esophageal Adenocarcinoma.

Authors:  Christina Oetzmann von Sochaczewski; Thomas Haist; Michael Pauthner; Markus Mann; Susanne Braun; Christian Ell; Dietmar Lorenz
Journal:  World J Surg       Date:  2020-04       Impact factor: 3.352

3.  The effect of age on survival after endoscopic resection versus surgery for T1a esophageal cancer.

Authors:  Vignesh Raman; Oliver K Jawitz; Soraya L Voigt; Chi-Fu J Yang; David H Harpole; Thomas A D'Amico; Matthew G Hartwig
Journal:  J Thorac Cardiovasc Surg       Date:  2019-12-02       Impact factor: 5.209

4.  Surveillance Implications of Recurrence Patterns in Early Node-Negative Esophageal Adenocarcinoma.

Authors:  Tamar B Nobel; Jennifer Livschitz; Xin Xin Xing; Arianna Barbetta; Meier Hsu; Kay See Tan; Smita Sihag; David R Jones; Daniela Molena
Journal:  Ann Thorac Surg       Date:  2019-07-16       Impact factor: 4.330

5.  Development and validation of a nomogram for preoperative prediction of lymph node metastasis in pathological T1 esophageal squamous cell carcinoma.

Authors:  Ling Chen; Kaiming Peng; Ziyan Han; Shaobin Yu; Zhixin Huang; Hui Xu; Mingqiang Kang
Journal:  Medicine (Baltimore)       Date:  2022-05-20       Impact factor: 1.817

6.  Is the new distribution of early esophageal adenocarcinoma stages improving the prognostic prediction of the 8th edition of the TNM staging system for esophageal cancer?

Authors:  Ran Mo; Chen Chen; Liang Pan; Ao Yu; Dongjin Wang; Tao Wang
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

7.  A Clinical Nomogram for Predicting Node-positive Disease in Esophageal Cancer.

Authors:  Tara R Semenkovich; Yan Yan; Melanie Subramanian; Bryan F Meyers; Benjamin D Kozower; Ruben Nava; G Alexander Patterson; Daniel Kreisel; Varun Puri
Journal:  Ann Surg       Date:  2021-06-01       Impact factor: 13.787

8.  Clinical nomogram for lymph node metastasis in pathological T1 esophageal squamous cell carcinoma: a multicenter retrospective study.

Authors:  Dong Tian; Kai-Yuan Jiang; Heng Huang; Shun-Hai Jian; Yin-Bin Zheng; Xiao-Guang Guo; Hong-Yun Li; Jing-Qiu Zhang; Ke-Xuan Guo; Hong-Ying Wen
Journal:  Ann Transl Med       Date:  2020-03

9.  Predicting lymph node metastases with endoscopic resection in cT2N0M0 oesophageal cancer: A systematic review and meta-analysis.

Authors:  Ali Al-Kaabi; Rachel S van der Post; Jonathan Huising; Camiel Rosman; Iris D Nagtegaal; Peter D Siersema
Journal:  United European Gastroenterol J       Date:  2019-09-25       Impact factor: 4.623

10.  Modeling the impact of delaying surgery for early esophageal cancer in the era of COVID-19.

Authors:  Maren E Shipe; Jordan J Baechle; Stephen A Deppen; Erin A Gillaspie; Eric L Grogan
Journal:  Surg Endosc       Date:  2020-11-02       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.